Text Size

Total Hip Registry

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Stryker Orthopaedics
DePuy Orthopaedics
ConforMIS, Inc.
Information provided by (Responsible Party):
R. David Heekin, Heekin Orthopedic Research Institute
ClinicalTrials.gov Identifier:
NCT01133249
First received: May 26, 2010
Last updated: March 19, 2013
Last verified: March 2013
History of Changes
  Purpose

Objective

Describe the clinical and demographic characteristics of patients who undergo hip arthroplasty and document post operative outcomes.

Examine the relationship between processes of care, hospital and surgeon associated outcomes

Provide expanded data to characterize existing and evolving practice patterns, delivery of care, and resource utilization in the management of knee arthroplasty patients.

Analyze and design ancillary studies to address unanswered questions.

Disseminate findings through publication in peer-reviewed scientific journals.


Condition
Osteoarthritis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Total Hip Registry

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Further study details as provided by Heekin Orthopedic Research Institute:

Primary Outcome Measures:
  • Harris Hip Score [ Time Frame: 2 weeks, 6 weeks, 3 months, 6 months, 1, 2, 5, 10 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 942
Study Start Date: July 2005
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Total hip
all consented patients receiving total hip arthroplasty

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Population: All total hip replacements

Selection: Males and non-pregnant females over the age of 21

Criteria

Inclusion Criteria:

  • Patient requires total hip Arthroplasty
  • Patient has signed IRB approved informed consent

Exclusion Criteria:

  • Less than 21 years of age
  • Patient is a prisoner
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01133249

Locations
United States, Florida
Heekin Orthopedic Specialists
Jacksonville, Florida, United States, 32204
Sponsors and Collaborators
Heekin Orthopedic Research Institute
Stryker Orthopaedics
DePuy Orthopaedics
ConforMIS, Inc.
Investigators
Principal Investigator: Richard D Heekin, MD Heekin Orthopedic Specialists
  More Information

No publications provided

Responsible Party: R. David Heekin, R. David Heekin, M.D., Heekin Orthopedic Research Institute
ClinicalTrials.gov Identifier: NCT01133249     History of Changes
Other Study ID Numbers: 05-09-01
Study First Received: May 26, 2010
Last Updated: March 19, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Heekin Orthopedic Research Institute:
total hip

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 21, 2013